GLG Partners’s DexCom DXCM Stock Holding History

GLG Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-127,744	Closed	-$2.8M	–	396
2016 Q3	$2.8M	Buy	+127,744	New	+$2.84M	0.09%	259

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

GLG Partners's DXCM Position: Q4 2016 in Review

GLG Partners sold out of DexCom (DXCM) in Q4 2016, closing a stake of 127,744 shares — an estimated $2.8M sold.

GLG Partners first reported a position in DXCM in Q3 2016 and held it in 1 quarter. The position peaked at $2.8M in Q3 2016. 316 funds tracked by Wall St. Rank hold DXCM as of Q4 2016.

GLG Partners reported no remaining DexCom position as of Q4 2016 after selling out during the quarter.
GLG Partners sold 127,744 DexCom shares in Q4 2016, an estimated $2.8M.
GLG Partners first reported a position in DexCom in Q3 2016 and held it in 1 quarter.
GLG Partners's DexCom position peaked at $2.8M in Q3 2016.
316 funds tracked by Wall St. Rank held DexCom as of Q4 2016.

Based on GLG Partners's 13F filing for Q4 2016, filed 14 Feb 2017.